Industry News
DAC Labs seeks commercial scale-up with COO appointment
To lead commercial scale-up of its direct air capture technology, DAC Labs has appointed former Macquarie Group executive Emma Quigly-Hall as Chief Operating Officer. [ + ]
The University of Sydney formalises cervical cancer elimination partnership
The success of a cervical cancer elimination program has led to the signing of a memorandum of understanding with the Timor-Leste Ministry of Health. [ + ]
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology paper reveals the science behind its immune system platform, Sofra. [ + ]
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics discussing their lived experience. [ + ]
QIMR Berghofer signs strategic partnership with Nakanoshima Qross
QIMR Berghofer and Japanese biomedical innovation hub Nakanoshima Qross have signed a strategic partnership agreement aimed at harnessing combined medical research expertise. [ + ]
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has signed a strategic partnership with Monash University. [ + ]
Dr Chris Baldwin is new HaemaLogiX CEO and Managing Director
Having commenced in January, Dr Chris Baldwin is clinical stage Australian biotechnology company HaemaLogiX's new CEO and Managing Director. [ + ]
Beckman Coulter Life Sciences announces Automata partnership
Beckman Coulter Life Sciences has announced a strategic partnership with Automata — to accelerate AI-ready laboratory automation. [ + ]
Archer completes potassium sensing alpha prototype
Quantum technology company Archer Materials Limited has developed an early Biochip prototype designed to detect chronic kidney disease. [ + ]
Farm animals and aquaculture cryopreservation partnership announced
Vitrafy Life Sciences Limited has announced that it has entered a 12-month exclusive agreement with French-based IMV Technologies. [ + ]
Vaxxas appoints former Merck Global Vaccines President David Peacock as CEO
To lead the commercialisation of Vaxxas's proprietary high‑density microarray patch (HD‑MAP) vaccination technology, David Peacock has been appointed CEO. [ + ]
Optics11 Life appoints Jacquelien ten Dam as CEO
Optics11 Life plans to accelerate its commercial growth in key markets while building strategic partnerships to extend the reach and impact of mechanobiology. [ + ]
Epilepsy pioneer elected President of Aust Academy of Science
Laureate Professor Sam Berkovic — one of the world's most respected neurologists — has been elected President of the Australian Academy of Science. [ + ]
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early warning sign of faster biological aging. [ + ]
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured in the laboratory — that are capable of destroying glioblastoma cells. [ + ]
